Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Short Bowel Syndrome | 4 | 2022 | 60 | 2.950 |
Why?
|
| Fat Emulsions, Intravenous | 10 | 2024 | 71 | 2.810 |
Why?
|
| Enterocolitis, Necrotizing | 11 | 2023 | 237 | 2.720 |
Why?
|
| Parenteral Nutrition | 12 | 2024 | 186 | 2.280 |
Why?
|
| Cholestasis | 6 | 2024 | 161 | 1.780 |
Why?
|
| Intestinal Diseases | 4 | 2022 | 83 | 1.700 |
Why?
|
| Infant, Premature | 9 | 2024 | 800 | 1.620 |
Why?
|
| Ostomy | 2 | 2023 | 11 | 1.600 |
Why?
|
| Fish Oils | 8 | 2024 | 82 | 1.530 |
Why?
|
| Infant, Newborn, Diseases | 4 | 2023 | 174 | 1.280 |
Why?
|
| Liver Diseases | 4 | 2022 | 384 | 1.180 |
Why?
|
| Infant, Newborn | 27 | 2024 | 8120 | 1.150 |
Why?
|
| Soybean Oil | 8 | 2024 | 65 | 1.000 |
Why?
|
| Intensive Care Units, Neonatal | 4 | 2023 | 311 | 0.970 |
Why?
|
| Infant Formula | 3 | 2020 | 98 | 0.910 |
Why?
|
| Infant | 19 | 2024 | 12355 | 0.810 |
Why?
|
| Infant, Premature, Diseases | 4 | 2024 | 239 | 0.730 |
Why?
|
| Milk, Human | 3 | 2020 | 295 | 0.730 |
Why?
|
| Central Venous Catheters | 1 | 2021 | 38 | 0.720 |
Why?
|
| Probiotics | 1 | 2023 | 209 | 0.710 |
Why?
|
| Catheterization, Central Venous | 1 | 2021 | 131 | 0.670 |
Why?
|
| Intestines | 5 | 2024 | 580 | 0.660 |
Why?
|
| Fetal Diseases | 1 | 2023 | 443 | 0.650 |
Why?
|
| Parenteral Nutrition, Total | 2 | 2020 | 117 | 0.610 |
Why?
|
| Argininosuccinate Lyase | 4 | 2018 | 60 | 0.600 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2019 | 191 | 0.600 |
Why?
|
| Enterocytes | 2 | 2018 | 70 | 0.600 |
Why?
|
| Neonatologists | 1 | 2017 | 18 | 0.590 |
Why?
|
| Thrombosis | 1 | 2021 | 520 | 0.520 |
Why?
|
| Lower Extremity Deformities, Congenital | 1 | 2014 | 13 | 0.480 |
Why?
|
| Mouth Abnormalities | 1 | 2014 | 15 | 0.480 |
Why?
|
| Syndactyly | 1 | 2014 | 24 | 0.480 |
Why?
|
| Maxilla | 1 | 2014 | 36 | 0.480 |
Why?
|
| Apnea | 1 | 2014 | 31 | 0.470 |
Why?
|
| Fingers | 1 | 2014 | 65 | 0.470 |
Why?
|
| Mandible | 1 | 2014 | 78 | 0.460 |
Why?
|
| Eye Abnormalities | 1 | 2014 | 108 | 0.450 |
Why?
|
| Knee Joint | 1 | 2014 | 108 | 0.450 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 2014 | 67 | 0.430 |
Why?
|
| Cleft Lip | 1 | 2014 | 127 | 0.420 |
Why?
|
| Cleft Palate | 1 | 2014 | 140 | 0.420 |
Why?
|
| Humans | 39 | 2024 | 122853 | 0.410 |
Why?
|
| Nitric Oxide | 4 | 2018 | 439 | 0.410 |
Why?
|
| Urogenital Abnormalities | 1 | 2014 | 168 | 0.400 |
Why?
|
| Intestinal Perforation | 2 | 2024 | 59 | 0.400 |
Why?
|
| Infant, Extremely Low Birth Weight | 3 | 2024 | 38 | 0.380 |
Why?
|
| Enteral Nutrition | 2 | 2023 | 248 | 0.360 |
Why?
|
| Food, Fortified | 2 | 2020 | 96 | 0.330 |
Why?
|
| Triglycerides | 4 | 2022 | 560 | 0.320 |
Why?
|
| Scrotum | 1 | 2009 | 23 | 0.320 |
Why?
|
| Abnormalities, Multiple | 1 | 2014 | 973 | 0.310 |
Why?
|
| Argininosuccinic Aciduria | 3 | 2014 | 47 | 0.310 |
Why?
|
| Dietary Supplements | 2 | 2023 | 462 | 0.300 |
Why?
|
| Tuberculosis, Miliary | 1 | 2007 | 11 | 0.290 |
Why?
|
| Testis | 1 | 2009 | 407 | 0.270 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2007 | 238 | 0.250 |
Why?
|
| Gestational Age | 3 | 2024 | 1119 | 0.250 |
Why?
|
| Olive Oil | 2 | 2022 | 22 | 0.250 |
Why?
|
| Birth Weight | 2 | 2023 | 334 | 0.240 |
Why?
|
| Cohort Studies | 3 | 2023 | 4673 | 0.240 |
Why?
|
| Laparotomy | 1 | 2024 | 135 | 0.220 |
Why?
|
| Ileus | 1 | 2023 | 10 | 0.210 |
Why?
|
| Arginine | 4 | 2018 | 303 | 0.210 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2007 | 442 | 0.210 |
Why?
|
| Drainage | 1 | 2024 | 254 | 0.210 |
Why?
|
| Cost-Benefit Analysis | 1 | 2024 | 498 | 0.200 |
Why?
|
| Intestinal Mucosa | 2 | 2018 | 774 | 0.200 |
Why?
|
| Feeding Behavior | 1 | 2007 | 678 | 0.200 |
Why?
|
| Retrospective Studies | 9 | 2024 | 15927 | 0.200 |
Why?
|
| Bilirubin | 1 | 2022 | 129 | 0.190 |
Why?
|
| Docosahexaenoic Acids | 2 | 2019 | 66 | 0.190 |
Why?
|
| Fatty Acids | 2 | 2020 | 339 | 0.190 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 231 | 0.180 |
Why?
|
| Energy Intake | 2 | 2020 | 450 | 0.180 |
Why?
|
| Male | 16 | 2024 | 59866 | 0.180 |
Why?
|
| Ileum | 1 | 2020 | 134 | 0.170 |
Why?
|
| Swine | 6 | 2020 | 1158 | 0.170 |
Why?
|
| Catheters, Indwelling | 1 | 2021 | 156 | 0.170 |
Why?
|
| Micronutrients | 1 | 2020 | 67 | 0.170 |
Why?
|
| Growth | 1 | 2020 | 107 | 0.170 |
Why?
|
| Infant, Low Birth Weight | 1 | 2020 | 164 | 0.160 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2019 | 1033 | 0.160 |
Why?
|
| Premature Birth | 2 | 2020 | 380 | 0.160 |
Why?
|
| Female | 14 | 2024 | 65278 | 0.160 |
Why?
|
| Swine Diseases | 2 | 2020 | 36 | 0.160 |
Why?
|
| Milk | 1 | 2019 | 118 | 0.160 |
Why?
|
| Length of Stay | 1 | 2024 | 1281 | 0.160 |
Why?
|
| Cattle | 1 | 2019 | 559 | 0.150 |
Why?
|
| Emulsions | 2 | 2019 | 65 | 0.150 |
Why?
|
| Metabolome | 1 | 2020 | 294 | 0.150 |
Why?
|
| Bile Acids and Salts | 1 | 2020 | 237 | 0.150 |
Why?
|
| Sepsis | 2 | 2019 | 479 | 0.150 |
Why?
|
| Citrulline | 1 | 2018 | 84 | 0.150 |
Why?
|
| United States | 2 | 2023 | 10538 | 0.150 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2023 | 710 | 0.140 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 354 | 0.140 |
Why?
|
| Fetal Development | 1 | 2018 | 111 | 0.140 |
Why?
|
| Animals | 11 | 2020 | 33923 | 0.140 |
Why?
|
| Continuous Positive Airway Pressure | 2 | 2008 | 51 | 0.140 |
Why?
|
| Colitis | 1 | 2018 | 156 | 0.130 |
Why?
|
| Disease Models, Animal | 4 | 2014 | 4308 | 0.130 |
Why?
|
| Critical Illness | 1 | 2021 | 594 | 0.130 |
Why?
|
| Smad7 Protein | 1 | 2016 | 7 | 0.130 |
Why?
|
| Colonic Neoplasms | 1 | 2018 | 254 | 0.130 |
Why?
|
| Treatment Outcome | 4 | 2021 | 12070 | 0.120 |
Why?
|
| Microbiota | 1 | 2020 | 392 | 0.120 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 3319 | 0.120 |
Why?
|
| Pregnancy | 4 | 2023 | 7126 | 0.120 |
Why?
|
| Neutrophil Infiltration | 1 | 2014 | 65 | 0.110 |
Why?
|
| Compassionate Use Trials | 1 | 2014 | 14 | 0.110 |
Why?
|
| Inflammation | 2 | 2018 | 1400 | 0.110 |
Why?
|
| Observational Studies as Topic | 1 | 2014 | 78 | 0.110 |
Why?
|
| Child | 7 | 2024 | 24168 | 0.110 |
Why?
|
| Surveys and Questionnaires | 1 | 2023 | 3641 | 0.110 |
Why?
|
| Phospholipids | 1 | 2014 | 107 | 0.110 |
Why?
|
| Transforming Growth Factor beta | 1 | 2016 | 461 | 0.110 |
Why?
|
| Infant, Extremely Premature | 1 | 2014 | 81 | 0.110 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 234 | 0.100 |
Why?
|
| Congresses as Topic | 1 | 2014 | 164 | 0.100 |
Why?
|
| Hyperbilirubinemia | 1 | 2012 | 43 | 0.100 |
Why?
|
| Mice, Knockout | 3 | 2018 | 3782 | 0.100 |
Why?
|
| RNA Interference | 1 | 2014 | 497 | 0.100 |
Why?
|
| Interleukin-6 | 1 | 2014 | 395 | 0.100 |
Why?
|
| Red-Cell Aplasia, Pure | 1 | 2002 | 3 | 0.100 |
Why?
|
| Transfection | 1 | 2014 | 1076 | 0.100 |
Why?
|
| Macrophages | 1 | 2016 | 613 | 0.100 |
Why?
|
| Cell Line | 2 | 2014 | 2787 | 0.100 |
Why?
|
| Cyclosporine | 1 | 2002 | 146 | 0.090 |
Why?
|
| Bronchopulmonary Dysplasia | 2 | 2017 | 184 | 0.090 |
Why?
|
| Cell Movement | 1 | 2014 | 838 | 0.090 |
Why?
|
| Animals, Newborn | 1 | 2014 | 1007 | 0.090 |
Why?
|
| Risk | 1 | 2012 | 744 | 0.090 |
Why?
|
| Prenatal Diagnosis | 1 | 2014 | 581 | 0.090 |
Why?
|
| Bone Marrow | 1 | 2002 | 319 | 0.090 |
Why?
|
| Texas | 2 | 2020 | 3542 | 0.090 |
Why?
|
| Leukemia, Myelomonocytic, Acute | 1 | 1999 | 7 | 0.090 |
Why?
|
| Lipids | 1 | 2012 | 512 | 0.080 |
Why?
|
| Fanconi Anemia | 1 | 1999 | 49 | 0.080 |
Why?
|
| Hospitals, Pediatric | 1 | 2014 | 779 | 0.080 |
Why?
|
| High-Frequency Ventilation | 1 | 2008 | 16 | 0.080 |
Why?
|
| Iatrogenic Disease | 1 | 2009 | 132 | 0.080 |
Why?
|
| Immunosuppressive Agents | 1 | 2002 | 646 | 0.070 |
Why?
|
| Minisatellite Repeats | 1 | 2007 | 43 | 0.070 |
Why?
|
| Genetic Therapy | 1 | 2012 | 706 | 0.070 |
Why?
|
| Rats | 1 | 2014 | 3665 | 0.070 |
Why?
|
| Apoptosis | 1 | 2014 | 1792 | 0.070 |
Why?
|
| Prospective Studies | 2 | 2020 | 5996 | 0.070 |
Why?
|
| Congenital Abnormalities | 1 | 2009 | 243 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 2827 | 0.060 |
Why?
|
| Wounds and Injuries | 1 | 2009 | 363 | 0.060 |
Why?
|
| Mice | 4 | 2016 | 17647 | 0.060 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2006 | 168 | 0.060 |
Why?
|
| Spontaneous Perforation | 1 | 2024 | 4 | 0.060 |
Why?
|
| Liver Transplantation | 2 | 2024 | 1034 | 0.060 |
Why?
|
| Time Factors | 1 | 2014 | 6202 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 1881 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 3479 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2020 | 3245 | 0.050 |
Why?
|
| Lung Diseases | 1 | 2006 | 385 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 3 | 2018 | 4392 | 0.050 |
Why?
|
| Health Care Costs | 1 | 2024 | 364 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2024 | 1006 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2024 | 1407 | 0.040 |
Why?
|
| Aspartate Aminotransferases | 1 | 2020 | 76 | 0.040 |
Why?
|
| Child, Preschool | 3 | 2024 | 13858 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2024 | 1000 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 1999 | 3083 | 0.040 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2017 | 16 | 0.040 |
Why?
|
| Phytosterols | 1 | 2017 | 27 | 0.030 |
Why?
|
| Body Composition | 1 | 2019 | 479 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2017 | 151 | 0.030 |
Why?
|
| RAW 264.7 Cells | 1 | 2016 | 36 | 0.030 |
Why?
|
| I-kappa B Kinase | 1 | 2016 | 61 | 0.030 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2017 | 106 | 0.030 |
Why?
|
| Risk Factors | 2 | 2020 | 9928 | 0.030 |
Why?
|
| Child Development | 1 | 2017 | 250 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 292 | 0.030 |
Why?
|
| Diet | 1 | 2020 | 1112 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2018 | 907 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2016 | 462 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 3033 | 0.030 |
Why?
|
| Argininosuccinate Synthase | 1 | 2011 | 20 | 0.020 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2017 | 469 | 0.020 |
Why?
|
| Nitrites | 1 | 2011 | 45 | 0.020 |
Why?
|
| Adolescent | 2 | 2024 | 19037 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2012 | 339 | 0.020 |
Why?
|
| Nitric Oxide Synthase | 1 | 2011 | 186 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 2396 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 351 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2002 | 301 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 2002 | 302 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 664 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 1999 | 359 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2011 | 529 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2002 | 1168 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 2961 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2011 | 882 | 0.020 |
Why?
|
| Adult | 1 | 2007 | 28926 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2011 | 1760 | 0.020 |
Why?
|
| Liver | 1 | 2012 | 1858 | 0.010 |
Why?
|
| Hypertension | 1 | 2012 | 1275 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2016 | 4524 | 0.010 |
Why?
|